CPT codes are provided for informational purposes only and do not guarantee reimbursement. Verify code applicability and coverage with the relevant payer and your billing department before submitting claims. CPT® is a registered trademark of the American Medical Association.
Similar Posts

CMAT Advantage Roadmap—What Physicians Can Expect in 2025 and Beyond
The CMAT Advantage roadmap outlines a multi-year plan for expanding physician capabilities in preventive vascular and autonomic diagnostics. As screening guidelines tighten and reimbursement models evolve, this roadmap helps clinics align their capital planning, workflow design, and billing strategies with what is coming next. Why Publish a CMAT Advantage Roadmap Now? To keep your clinic…
Introduction to the TM-Flow System
Why vascular & autonomic screening matter for modern practice In This Article Early detection of vascular and autonomic nerve issues can improve patient outcomes and grow your practice. The TM-Flow System is an in-office diagnostic tool that screens for key health markers. These include peripheral arterial disease (PAD), autonomic imbalance, and small-fiber neuropathy. A full…
Vascular and Neuropathy Screening in Wound Care Clinics — The CMAT Advantage™ System
CPT codes are provided for informational purposes only and do not guarantee reimbursement. Verify code applicability and coverage with the relevant payer and your billing department before submitting claims. CPT® is a registered trademark of the American Medical Association.
How HealthWright Technologies Enables Physicians to Streamline Non-Invasive Cardiovascular Diagnostics
1 | Why “Fast, Non-Invasive & Billable” Is the New Standard Manual Doppler ABI is still guideline-recommended, yet real-world limitations—slow workflows, operator variability, and false-negatives in calcified vessels—often push patients past the early-intervention window. Modern outpatient settings need diagnostics that are: HealthWright Technologies Inc satisfies all three with the CMAT Advantage, a single CMAT device…
CMAT Advantage vs. Traditional PAD Screening Devices: What Doctors Need to Know
1. The Evolving Landscape of PAD Screening Peripheral arterial disease (PAD) affects nearly 20 million U.S. adults, yet fewer than half are diagnosed before symptoms such as claudication appear.¹ Most clinics still depend on: Recent studies reveal sensitivity gaps in diabetic or calcified vessels and workflow bottlenecks that suppress case-finding. In response, HealthWright Technologies Inc…
Financial & Reimbursement Considerations for the TM-Flow System
TM-Flow System: Financial Considerations Beyond its clinical benefits, the TM-Flow System provides tangible economic value for clinics. With proper billing and documentation, practices can enhance patient care through preventive diagnostics while performing tests associated with established CPT codes. Understanding the Economic Value of Diagnostic Screening Modern primary care models are shifting from reactive care to…
